Neto Nelson Bf, Marin Luiz G, de Souza Bruna G, Moro Ana Ld, Nedel Wagner L
Intensive Care Unit, Hospital Bruno Born, Lajeado/RS, Brazil.
Intensive Care Unit, Hospital Nossa Senhora da Conceição, Porto Alegre/RS, Brazil.
J Intensive Care Soc. 2021 Feb;22(1):47-51. doi: 10.1177/1751143719898977. Epub 2020 Jan 14.
Combined antiretroviral therapy has led to significant decreases in morbidity and mortality in acquired immunodeficiency syndrome patients. Survival among these patients admitted to intensive care units has also improved in the last years. However, the prognostic predictors of human immunodeficiency vírus patients in intensive care units have not been adequately studied. The main objective of this study was to evaluate if non-adherence to antiretroviral therapy is a predictor of hospital mortality.
A unicentric, retrospective, cohort study composed of patients admitted to a 59-bed mixed intensive care unit including all patients with human immunodeficiency vírus infection. Patients were excluded if exclusive palliative care was established before completing 48 h of intensive care unit admission. Clinical and treatment data were obtained, including demographic records, underlying diseases, Simplified Acute Physiology III score at the time of intensive care unit admission, CD4 lymphocyte count, antiretroviral therapy adherence, admission diagnosis, human immunodeficiency vírus-related diseases, sepsis and use of mechanical ventilation and hemodialysis. The outcome analyzed was hospital mortality.
Overall, 167 patients were included in the study, and intensive care unit mortality was 34.7%. Multivariate analysis indicated that antiretroviral therapy adherence and the Simplified Acute Physiology 3 score were independently related to hospital mortality. antiretroviral therapy adherence was a protective factor (OR 0.2; 95% CI 0.05-0.71; = 0.01), and Simplified Acute Physiology 3 (OR 1.04; 95% CI 1.01-1.08; < 0.01) was associated with increased hospital mortality.
Non-adherence to antiretroviral therapy is associated with hospital mortality in this population. Highly active antiretroviral therapy non-adherence may be associated with other comorbidities that may be associated with a worst prognosis in this scenario.
联合抗逆转录病毒疗法已使获得性免疫缺陷综合征患者的发病率和死亡率显著降低。近年来,入住重症监护病房的这些患者的生存率也有所提高。然而,对重症监护病房中人类免疫缺陷病毒患者的预后预测因素尚未进行充分研究。本研究的主要目的是评估抗逆转录病毒治疗的不依从性是否是医院死亡率的预测因素。
一项单中心、回顾性队列研究,研究对象为入住拥有59张床位的综合重症监护病房的患者,包括所有人类免疫缺陷病毒感染患者。如果在重症监护病房入院48小时前就确定了单纯姑息治疗,则将患者排除。获取临床和治疗数据,包括人口统计学记录、基础疾病、重症监护病房入院时的简化急性生理学III评分、CD4淋巴细胞计数、抗逆转录病毒治疗依从性、入院诊断、人类免疫缺陷病毒相关疾病、脓毒症以及机械通气和血液透析的使用情况。分析的结局指标是医院死亡率。
总体而言,167例患者纳入本研究,重症监护病房死亡率为34.7%。多变量分析表明,抗逆转录病毒治疗依从性和简化急性生理学3评分与医院死亡率独立相关。抗逆转录病毒治疗依从性是一个保护因素(比值比0.2;95%置信区间0.05 - 0.71;P = 0.01),而简化急性生理学3评分(比值比1.04;95%置信区间1.01 - 1.08;P < 0.01)与医院死亡率增加相关。
在该人群中,抗逆转录病毒治疗的不依从性与医院死亡率相关。高效抗逆转录病毒治疗的不依从性可能与其他合并症相关,而在这种情况下这些合并症可能与更差的预后相关。